Trial Profile
Helicobacter pylori eradication therapy with Vonoprazan-amoxicillin-clarithromycin triple therapy - effect on Helicobacter pylori clarithromycin resistance -
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- Acronyms P-CAB
- 23 Sep 2020 Status changed from recruiting to completed.
- 16 Sep 2015 New trial record